NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia

Background: A number of mutations have been reported to occur in patients with acute myeloid leukemia (AML), of which NPM1 and FLT3 gene mutations are the commonest and have important diagnostic and therapeutic implications, respectively. Material and Methods: Molecular testing for NPM1 and FLT3...

Full description

Bibliographic Details
Main Authors:	Shano Naseem, Jogeshwar Binota, Harpreet Virk, Neelam Varma, Subhash Varma, Pankaj Malhotra
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2021-01-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	Acute myeloid leukemia; Nucleophosmin 1(NPM1) mutation; FMS-like tyrosine kinase 3 (FLT3) mutation
Online Access:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1191

Similar Items

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype
by: Irina Stepanovna Martynkevich, et al.
Published: (2010-12-01)

The Impact of DNMT3A/FLT3-ITD/NPM1 on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: Long Su
Published: (2019-02-01)

Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
by: Daniele Florio, et al.
Published: (2024-01-01)

Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
by: Mona Salah, et al.
Published: (2021-06-01)

FMS-Like Tyrosine Kinase 3 ( FLT3 ) and Nucleophosmin 1 ( NPM1 ) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics
by: Narges Rezaei, et al.
Published: (2017-11-01)

FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
by: Hind Dehbi, et al.
Published: (2013-01-01)

Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile
by: Maria Elena Cabrera, et al.
Published: (2023-01-01)

NPM1 and FLT3-(ITD) Gene mutations and laboratory findings in patients with acute myeloid leukemia in Northwest of Iran
by: Sanaat Z, et al.
Published: (2014-10-01)

Comparison of high-resolution melting analysis with direct sequencing for detection of FLT3-TKD, FLT3-ITD and WT1 mutations in acute myeloid leukemia
by: Aida Mahmoudi, et al.
Published: (2021-01-01)

Mutación NPM1-A en pacientes cubanos con leucemia mieloide aguda, su coexistencia con otras alteraciones moleculares
by: Ana María Amor-Vigil, et al.

Analysis of NPM1 and FLT3 Mutations in Patients with Acute Myeloid Leukemia in Jeddah, Saudi Arabia: A Pilot Study
by: Raed Alserihi, et al.
Published: (2023-03-01)

Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis 
by: Huang Y, et al.
Published: (2019-05-01)

Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
by: Jean F. Kloppers, et al.
Published: (2021-06-01)

Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine
by: Biao Wang, et al.
Published: (2023-04-01)

Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
by: Anna Wojtuszkiewicz, et al.
Published: (2021-08-01)

NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML
by: Claudia Tregnago, et al.
Published: (2021-07-01)

NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
by: Ji Hoon Phi, et al.
Published: (2019-08-01)

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
by: Pimjai Niparuck, et al.
Published: (2019-01-01)

Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells
by: Liu Yan, et al.
Published: (2012-05-01)

Prognostic Relevance of <i>NPM1</i> and <i>FLT3</i> Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience
by: Erika Borlenghi, et al.
Published: (2022-09-01)

Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study
by: Tripon Florin, et al.
Published: (2019-07-01)

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
by: Dan Xu, et al.
Published: (2022-07-01)

Effect of Sulfur Mustard Toxicity on FLT3-ITD Gene Mutation in Sulfur Mustard Veterans
by: Hossein Ayatollahi, et al.
Published: (2018-07-01)

The Role of Nucleophosmin 1 (<i>NPM1</i>) Mutation in the Diagnosis and Management of Myeloid Neoplasms
by: Katalin Kelemen
Published: (2022-01-01)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
by: D Sorcini, et al.
Published: (2023-11-01)

NPM 1 Mutations in AML—The Landscape in 2023
by: Naman Sharma, et al.
Published: (2023-02-01)

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
by: Doh Yu Hwang, et al.
Published: (2020-05-01)

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
by: Peihong Wang, et al.
Published: (2021-07-01)

Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
by: Magda Zidan, et al.
Published: (2013-06-01)

Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report
by: Inés Martínez-Alfonzo, et al.
Published: (2022-02-01)

Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations
by: Zhuang Zuo, et al.
Published: (2023-01-01)

Frequency of FLT3/ITD Mutation in Patients with Acute Myeloid Leukaemia presenting at Combined Military Hospital, Rawalpindi
by: Anil Babar, et al.
Published: (2023-12-01)

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of <i>FLT3</i>-ITD in <i>NPM1</i> Mutated AML, Irrespectively of <i>FLT3</i>-ITD Allelic Burden
by: Paola Minetto, et al.
Published: (2020-12-01)

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation
by: Caroline Engen, et al.
Published: (2021-09-01)

Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
by: L. V. Guk, et al.
Published: (2022-11-01)

An HSP90 Inhibitor Overcomes FLT3 Inhibitor Resistance in FLT3/ITD-Positive Leukemia Cells with an N676K Mutation
by: Hiraku Ogata, et al.
Published: (2023-09-01)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
by: Jiewen Sun, et al.
Published: (2020-11-01)

Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
by: Ya B Balzhanova, et al.
Published: (2019-08-01)

NPM1 Gene Type A Mutation in Bulgarian Adults with Acute Myeloid Leukemia: A Single-Institution Study
by: Gueorgui Balatzenko, et al.
Published: (2014-02-01)

CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells
by: Vincenzo Maria Perriello, et al.
Published: (2021-01-01)